Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bartholin gland carcinoma.

L J Copeland, N Sneige, D M Gershenson

    Obstetrics and Gynecology
    |June 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Inclusion, diversity, equity, and access (IDEA) in gynecologic cancer clinical trials: A joint statement from GOG foundation and Society of Gynecologic Oncology (SGO).

    Gynecologic oncology·2023
    Same author

    MEK inhibitor resistance mechanisms and recent developments in combination trials.

    Cancer treatment reviews·2020
    Same author

    Pharmacokinetics of a novel extended half-life glycoPEGylated factor IX, nonacog beta pegol (N9-GP) in previously treated patients with haemophilia B: results from two phase 3 clinical trials.

    Haemophilia : the official journal of the World Federation of Hemophilia·2017
    Same author

    Low-grade serous carcinoma of the ovary or peritoneum.

    Annals of oncology : official journal of the European Society for Medical Oncology·2016
    Same author

    Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 cases.

    Gynecologic oncology·2015
    Same author

    Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978-2010).

    European journal of cancer (Oxford, England : 1990)·2014
    Same journal

    The Political Determinants of Obstetric Prescribing.

    Obstetrics and gynecology·2026
    Same journal

    Glucagon-Like Peptide-1 Receptor Agonists and Risk of Adverse Maternal Pregnancy Outcomes: A Systematic Review and Meta-analysis.

    Obstetrics and gynecology·2026
    Same journal

    Milestones in Motion: Vaginal Birth After Cesarean.

    Obstetrics and gynecology·2026
    Same journal

    Ebola Virus in Pregnancy.

    Obstetrics and gynecology·2026
    Same journal

    A Quality-Improvement Study Evaluating Three Postpartum Prophylactic Oxytocin Rates and Blood Loss After Vaginal Birth.

    Obstetrics and gynecology·2026
    Same journal

    The Effects of Climate Change on Obstetric and Gynecologic Health.

    Obstetrics and gynecology·2026
    See all related articles

    Bartholin gland carcinoma is rare, but a 30-year study shows a high survival rate with aggressive treatment. Management includes wide excision, lymph node dissection, and radiation for improved outcomes in Bartholin gland cancer.

    Area of Science:

    • Gynecologic Oncology
    • Surgical Pathology

    Background:

    • Bartholin gland tumors are rare, with limited data guiding their management.
    • Clinical experience with Bartholin gland carcinoma is scarce, necessitating further investigation.

    Purpose of the Study:

    • To summarize a 30-year clinical experience with Bartholin gland carcinoma.
    • To evaluate the efficacy of surgical and adjuvant treatment modalities.

    Main Methods:

    • Retrospective analysis of 36 patients diagnosed with Bartholin gland carcinoma over 30 years.
    • Review of FIGO staging, histopathological cell types, lymph node status, recurrence patterns, and treatment outcomes.
    • Assessment of treatment strategies including wide excision, lymphadenectomy, and radiation therapy.

    Main Results:

    Related Experiment Videos

    • A five-year survival rate of 84% was observed in 36 patients.
    • Squamous cell carcinoma was the most common type (27 cases).
    • 47% of patients with lymph node dissections had nodal metastases; 11 remained disease-free.
    • Local recurrences were lower in patients receiving radiation (7%) compared to those who did not (27%).

    Conclusions:

    • Wide excision, ipsilateral inguinal lymphadenectomy, and adjunctive irradiation yield excellent results for Bartholin gland carcinoma.
    • Aggressive surgical management combined with adjuvant radiation is crucial for improving survival and reducing recurrence.
    • Multidisciplinary approach is essential for optimal management of this rare malignancy.